The Telomerase Template Antagonist GRN163L Alters MDA-MB-231 Breast Cancer Cell Morphology, Inhibits Growth, and Augments the Effects of Paclitaxel

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-1188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Berberine Inhibits NLRP3 Inflammasome Pathway in Human Triple-Negative Breast Cancer MDA-MB-231 Cell

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2019English

Ginsenoside Rg3Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells

Journal of Cancer Prevention
2013English

Peptide SA12 Inhibits Proliferation of Breast Cancer Cell Lines McF-7 and MDA-MB-231 Through G0/G1 Phase Cell-Cycle Arrest

OncoTargets and Therapy
OncologyPharmacology
2018English

Suppression of Spry4 Enhances Cancer Stem Cell Properties of Human MDA-MB-231 Breast Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2016English

Unusual Roles of Caspase-8 in Triple-Negative Breast Cancer Cell Line MDA-MB-231

International Journal of Oncology
Cancer ResearchOncology
2016English

MEKK2 Regulates Paxillin Ubiquitylation and Localization in MDA-MB 231 Breast Cancer Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2014English

Fangjihuangqi Decoction Inhibits MDA‐MB‐231 Cell Invasion in Vitro and Decreases Tumor Growth and Metastasis in Triple‐negative Breast Cancer Xenografts Tumor Zebrafish Model

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Effects of Rotary Cell Culture System‐simulated Microgravity on the Ultrastructure and Biological Behavior of Human MDA‐MB‐231 Breast Cancer Cells

Precision Radiation Oncology
2019English

Synthetic Demethylwedelolactones Derivatives Inhibit Invasive Growth of Mda-Mb-231 Breast Cancer Cells in Vitro and in Vivo

Biophysical Journal
Biophysics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy